These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes. Subramanian G, McAfee JG, Blair RJ, Kallfelz FA, Thomas FD. J Nucl Med; 1975 Aug; 16(8):744-55. PubMed ID: 170385 [Abstract] [Full Text] [Related]
26. Effects of alternative reconstitution procedures on the labelling efficiency and in vitro stability of 99Tcm-labelled radiopharmaceuticals. Bogsrud TV, Chen MN, Herold TJ, Mahoney DW, Hung JC. Nucl Med Commun; 1999 Jan; 20(1):61-5. PubMed ID: 9949414 [Abstract] [Full Text] [Related]
27. A new method for assessing 99Tcm-MDP bone uptake from a bone scan image: quantitative measurement of radioactivity in global skeletal regions of interest. D'Addabbo A, Rubini G, Mele M, Lauriero F. Nucl Med Commun; 1992 Jan; 13(1):55-60. PubMed ID: 1594171 [Abstract] [Full Text] [Related]
28. 99Tcm-MDP Imaging of Osteopetrosis: Case Report. Zheng LC, OuYang XL, Liu GC, Zhang WJ, Zhang XM. Medicine (Baltimore); 2015 Jun; 94(22):e929. PubMed ID: 26039130 [Abstract] [Full Text] [Related]
29. [Evaluation of 113mIn-DTPMP and 99mTc-MDP for bone scanning]. Yang JS. Zhonghua Fang She Xue Za Zhi; 1984 Feb; 18(1):58-62. PubMed ID: 6236062 [No Abstract] [Full Text] [Related]
30. 99Tcm-p-aminohippuric acid as a new renal agent. Djokić D, Janković D, Maksin T, Jaksić E, Beatović S, Han R. Nucl Med Commun; 1999 Dec; 20(12):1133-40. PubMed ID: 10664994 [Abstract] [Full Text] [Related]
32. Studies on 177Lu-labeled methylene diphosphonate as potential bone-seeking radiopharmaceutical for bone pain palliation. Abbasi IA. Nucl Med Biol; 2011 Apr; 38(3):417-25. PubMed ID: 21492790 [Abstract] [Full Text] [Related]
33. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication. Buell U, Kleinhans E, Zorn-Bopp E, Reuschel W, Muenzing W, Moser EA, Seiderer M. J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854 [Abstract] [Full Text] [Related]
35. The role of 99Tcm-sestamibi scintigraphy in the staging and prediction of the therapeutic response of stage IV neuroblastoma: comparison with 131I-MIBG and 99Tcm-MDP scintigraphy. Burak Z, Yüksel DA, Cetingül N, Kantar M, Ozkiliç H, Moretti JL. Nucl Med Commun; 1999 Nov; 20(11):991-1000. PubMed ID: 10572908 [Abstract] [Full Text] [Related]
37. Biokinetics of bone tracers by means of deconvolution analysis--comparison of 99mTc MDP, 99mTc DPD and 99mTc EHDP. Knop J, Stritzke P, Kröger E, Schneider C, Wasmus G. Nuklearmedizin; 1982 Aug; 21(4):145-9. PubMed ID: 6216459 [Abstract] [Full Text] [Related]
38. Radioleucoscintigraphy in osteoarthritis. Is there an inflammatory component? al-Janabi MA, Solanki K, Critchley M, Smith ML, Britton KE, Huskisson EC. Nucl Med Commun; 1992 Oct; 13(10):706-12. PubMed ID: 1491834 [Abstract] [Full Text] [Related]